Herpes Simplex News and Research

RSS
Herpes simplex is a viral disease caused by herpes simplex viruses; both herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) cause herpes simplex. Infection with the herpes virus is categorized into one of several distinct disorders based on the site of infection.
Amgen's IMLYGIC receives positive opinion from CHMP for treatment of melanoma

Amgen's IMLYGIC receives positive opinion from CHMP for treatment of melanoma

FDA permits marketing of first CSF nucleic acid-based test for detection of multiple pathogens

FDA permits marketing of first CSF nucleic acid-based test for detection of multiple pathogens

Clinical study data on Mallinckrodt's H.P. Acthar Gel to be presented at ACR 2015

Clinical study data on Mallinckrodt's H.P. Acthar Gel to be presented at ACR 2015

Luminex receives rapid clearance from FDA for ARIES System and ARIES HSV 1&2 Assay

Luminex receives rapid clearance from FDA for ARIES System and ARIES HSV 1&2 Assay

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

Quest Diagnostics receives FDA 510(k) clearance for Simplexa HSV 1 & 2 Direct molecular test

Blavatnik Biomedical Accelerator funds advanced biomedical research projects

Blavatnik Biomedical Accelerator funds advanced biomedical research projects

Researchers capture images of immune cell interactions rallying to destroy herpes simplex virus

Researchers capture images of immune cell interactions rallying to destroy herpes simplex virus

Reducing amyloid fibril levels in semen may help reduce transmission of HIV

Reducing amyloid fibril levels in semen may help reduce transmission of HIV

NanoViricides speeds up HerpeCide drug development program

NanoViricides speeds up HerpeCide drug development program

Findings may lead to more accurate diagnostic test, possible vaccine for oral and genital herpes

Findings may lead to more accurate diagnostic test, possible vaccine for oral and genital herpes

Anna Nele Meckler and Armelle Corpet to receive SNSF's 2015 Marie Heim-Vögtlin Prize

Anna Nele Meckler and Armelle Corpet to receive SNSF's 2015 Marie Heim-Vögtlin Prize

Roche announces FDA 510(k) clearance for cobas HSV 1 and 2 Test

Roche announces FDA 510(k) clearance for cobas HSV 1 and 2 Test

Talimogene laherparepvec treatment shows durable clinical responses in advanced-stage melanoma patients

Talimogene laherparepvec treatment shows durable clinical responses in advanced-stage melanoma patients

Modified cold sore (herpes) virus improves survival in stage IIIb to IV melanoma patients

Modified cold sore (herpes) virus improves survival in stage IIIb to IV melanoma patients

Modified herpes virus improves survival in melanoma patients

Modified herpes virus improves survival in melanoma patients

Roche announces FDA clearance for cobas Cdiff Test to detect C. difficile in stool specimens

Roche announces FDA clearance for cobas Cdiff Test to detect C. difficile in stool specimens

New approach to vaccine development is 97 per cent efficacious and  could eliminate shingles

New approach to vaccine development is 97 per cent efficacious and could eliminate shingles

New approach to vaccine development is 97 per cent efficacious and could eliminate shingles

New approach to vaccine development is 97 per cent efficacious and could eliminate shingles

NanoViricides' anti-viral drug candidates show promise in lethal animal model of dermal herpes infection

NanoViricides' anti-viral drug candidates show promise in lethal animal model of dermal herpes infection

French clinicians diagnose first case of rabies since 2003

French clinicians diagnose first case of rabies since 2003